Takeda Pharmaceutical annual gross profit
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Takeda Pharmaceutical Gross Profit Growth & History (TAK)
Takeda Pharmaceutical's gross profit was ¥2.93T for fiscal 2026.
View full Takeda Pharmaceutical company overviewTakeda Pharmaceutical annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | ¥2.93T | −¥67.20B | −2.24% |
| 2025 | 2025-03-31 | ¥3.00T | ¥164.25B | +5.79% |
| 2024 | 2024-03-31 | ¥2.84T | ¥53.68B | +1.93% |
| 2023 | 2023-03-31 | ¥2.78T | ¥321.25B | +13.05% |
| 2022 | 2022-03-31 | ¥2.46T | ¥258.66B | +11.74% |
| 2021 | 2021-03-31 | ¥2.20T | ¥2.08B | +0.09% |
| 2020 | 2020-03-31 | ¥2.20T | ¥755.93B | +52.30% |
| 2019 | 2019-03-31 | ¥1.45T | ¥170.88B | +13.41% |
| 2018 | 2018-03-31 | ¥1.27T | ¥101.31B | +8.63% |
| 2017 | 2017-03-31 | ¥1.17T | — | — |
Takeda Pharmaceutical gross profit trends
Over the last five fiscal years, Takeda Pharmaceutical's gross profit increased from ¥2.20T to ¥2.93T, a change of ¥730.63B.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical source filings ↗